CE webinars

Upon Completion of this CE program, the audience will understand immunoglobulin therapy including administration, disease states used in therapy and treatment options.  The CE program will provide information on the neurological diseases associated with immunoglobulin therapy and provide insights on therapy options.

This webinar will provide a basic understanding of potential barriers to discharge to home infusion care. Potential strategies to address and/or overcome these barriers to allow an on-time discharge and sustainable transition to home will also be addressed.

Upon completion of this CE Program, the audience will understand breast cancer and the various subtypes that comprise the disease as well as a focused review of hormone receptor-positive (HR+) breast cancer risk factors and therapies. The CE will provide information on the treatment landscape for advanced disease, including current marketed specialty products and near-term pipeline agents.

This program will review biosimilars and their use in IBD and colorectal cancer.

This presentation provides an overview of the factors contributing to the development of gastroparesis and its pathophysiology. Also discussed is the disease's various drug procedural and nutrition treatments. 

This program will define, understand, and differentiate among the three definitions used to describe adult disease-related malnutrition. Participants will also understand the clinical and economic consequences of malnutrition. 

This program outlines the key parameters in nutrition assessment for the development of patient-specific PN solutions. The components of PN solution, the guidelines for safe PN delivery, and each step in the writing of a PN formula are also discussed in detail.